Pharmacokinetics in the human of a new synthetic vasopressin and oxytocin uterine antagonist.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Acta Endocrinologica

• Publication date

  1986-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1530/ACTA.0.1120465PMID 3751461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women

  1986cited by this paper
• THE EFFECT ON THE HUMAN UTERUS OF TWO NEWLY DEVELOPED COMPETITIVE INHIBITORS OF OXYTOCIN AND VASOPRESSIN

  1985cited by this paper
• Carboxy terminus of vasopressin required for activity but not binding

  1984cited by this paper
• Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor.

  1982cited by this paper
• Design of more potent and selective antagonists of the antidiuretic responses to arginine-vasopressin devoid of antidiuretic agonism.

  1982cited by this paper
• Conversion of triglycylvasopressin to lysine-vasopressin in man.

  1980cited by this paper
• Is vasopressin in the circulation of the dog freely filterable?

  1980cited by this paper
• A new extraction of arginine vasopressin from blood: The use of octadecasilyl-silica

  1980cited by this paper
• Pharmacokinetics of Oxytocin in the Human Subject

  1980cited by this paper
• PRIMARY DYSMENORRHOEA AND VASOPRESSIN

  1979cited by this paper
• Vasopressin Response and Terbutaline Inhibition of the Uterus

  1976cited by this paper
• Plasma ADH in normal Long-Evans rats and in Long-Evans rats heterozygous and homozygous for hypothalamic diabetes insipidus.

  1975cited by this paper
• Structural changes in the arginine vasopressin molecule that prolong its antidiuretic action.

  1974cited by this paper
• Mechanism of inactivation of vasopressin and oxytocin by the isolated perfused rat kidney.

  1973cited by this paper
• Determination of rate constants of drug elimination from the receptor compartment by an infusion method: neurohypophysial hormones and their structural analogues.

  1969cited by this paper
• The clearance and antidiuretic potency of neurohypophysial hormones in man, and their plasma binding and stability

  1969cited by this paper

• Administration of Atosiban, an Oxytocin Receptor Antagonist, Ameliorates Autistic-like Behaviors in a Female Rat Model of Valproic Acid-induced Autism.

  2024cites this paper
• Oxytocin modulates human chemosensory decoding of sex in a dose-dependent manner

  2021cites this paper
• Safety and Efficacy of Tocolytics for the Treatment of Spontaneous Preterm Labour.

  2019cites this paper
• Perception of social interaction compresses subjective duration in an oxytocin-dependent manner

  2018cites this paper
• Oxytocin for the treatment of drug and alcohol use disorders

  2016cites this paper
• Intranasal administration of oxytocin: Behavioral and clinical effects, a review

  2013cites this paper
• Atosiban for Preterm Labour

  2012cites this paper
• Critical appraisal and clinical utility of atosiban in the management of preterm labor

  2010cites this paper
• Atosiban as a tocolytic for the treatment of spontaneous preterm labor

  2008cites this paper
• Pharmacokinetics of Tocolytic Agents

  2004cites this paper
• Effects of Oxytocin Receptor Antagonist Atosiban on Pregnant Myometrium In Vitro

  2001cites this paper
• Atosiban, an oxytocin receptor blocking agent: pharmacokinetics and inhibition of milk ejection in dairy cows

  1999cites this paper
• Treatment of preterm labor with the oxytocin and vasopressin antagonist Atosiban

  1998cites this paper
• Comparison of in vitro and in vivo inhibitory effects of peptide and nonpeptide oxytocin antagonists on radioligand binding and uterine contractility of rats during pregnancy.

  1996cites this paper
• The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions.

  1995cites this paper
• Receptor‐mediated uterine effects of vasopressin and oxytocin in nonpregnant women

  1995cites this paper
• Hormonal and local regulation of uterine activity during parturition: part I — The oxytocin system

  1994cites this paper
• The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human.

  1994cites this paper
• Antagonists for the human oxytocin receptor: an in vitro study.

  1994cites this paper
• Modelling the pharmacokinetic distribution of macromolecules

  1994cites this paper
• Oxytocin antagonists in preterm labour and delivery.

  1993cites this paper
• 5 Oxytocin antagonists in preterm labour and delivery

  1993cites this paper
• Pharmacokinetic properties of the tocolytic agent [Mpa1d‐Tyr(Et)2, Thr4, Orn8]‐oxytocin (antocin) in healthy volunteers

  1993cites this paper
• Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.

  1993cites this paper
• 8 Heavy, painful periods

  1989cites this paper
• Heavy, painful periods.

  1989cites this paper
• Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.

  1989cites this paper
• Dysmenorrhoea

  1988cites this paper
• Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study

  1988cites this paper
• Can primary dysmenorrhea be alleviated by a vasopressen antagonist?

  1987cites this paper
• Can primary dysmenorrhea be alleviated by a vasopressin antagonist? Results of a pilot study.

  1987cites this paper
• Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study

  1987cites this paper